Moderna (NASDAQ: MRNA) has gone through its share of ups and downs in recent years, from posting soaring coronavirus vaccine revenue a few years ago to seeing demand for that product sink in the later ...

What’s Up With mRNA Research? A research nurse holds an injection of a BioNTech mRNA cancer immunotherapy for non-small cell ...

It's not a just a revolutionary and safe vaccine technology – mRNA could help make the best and most expensive drugs in the ...

The fears over mRNA-vaccine grant cancellations come after NIH staff members were instructed to compile a list of grants for ...

RNA cancer vaccines are at the forefront of next-generation cancer immunotherapy, showcasing significant potential.

In this interview, Technology Networks talked to Dr. Stacy Lindborg, president, chief executive officer and board member at IMUNON, Inc., who shares how its PlaCCine® platform could reshape vaccine ...

TechInvention and Belgium-based Quantoom Biosciences have entered a partnership to enhance the local manufacturing of mRNA ...

A vaccine kept patients free of pancreatic cancer for years, yet new reports say the NIH is advising against mentioning mRNA tech in grants.

U.S. health agency leadership and policymakers seem intent on undermining trust in mRNA, the technology that saved millions ...

Researchers found antibodies in those who reported the most positive moods were 16% higher when compared to those with lowest ...

Sanofi will commence a Phase I/II trial with its vaccine candidate in the next few days to start generating immunogenicity ...

Health secretary Robert F Kennedy Jr has previously claimed that mRNA covid vaccines killed more people than they saved ...